| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.073 | 0.2 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.2 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |